City

Seattle (1)

Condition

Recurrent Acute Leukemia of Ambiguous Lineage (2)

Recurrent Acute Lymphoblastic Leukemia (2)

Refractory Acute Leukemia of Ambiguous Lineage (2)

Refractory Acute Lymphoblastic Leukemia (2)

Recurrent Acute Myeloid Leukemia (1)

Recurrent Mixed Phenotype Acute Leukemia (1)

Refractory Acute Myeloid Leukemia (1)

Refractory Mixed Phenotype Acute Leukemia (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Phase

n/a (1)

phase 2 (1)

Sponsor

Children's Oncology Group (1)

University of Washington (1)

Collaborator

National Cancer Institute (NCI) (1)

Study Documents

Intervention Type

drug (2)

genetic (1)

other (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

recurrent acute leukemia of ambiguous lineage

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting

Recurrent Acute Leukemia of Ambiguous Lineage
+5 more

Biospecimen Collection
+12 more

(no location specified)

Mar 8, 2023

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

Completed

Has Results

Recurrent Acute Leukemia of Ambiguous Lineage
+5 more

Chemosensitivity Assay
+4 more

Seattle, Washington

Fred Hutch/University of Washington Cancer Consortium

Jun 29, 2022